BLPH

Bellerophon Therapeutics, Inc.
BLPH

Overview Fund Activity
Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

22 hedge funds and large institutions have $3.82M invested in Bellerophon Therapeutics, Inc. in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.

Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Jane Street
1
Jane Street
New York
$230K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.15M
3
Millennium Management
3
Millennium Management
New York
$75K
4
TI
4
Telemetry Investments
New York
$319K
5
TSS
5
Two Sigma Securities
New York
$35K

Top Sellers

1
Wells Fargo
1
Wells Fargo
California
$620K
2
ACM
2
ACT Capital Management
Pennsylvania
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$555K
4
HF
4
HRT Financial
New York
$0
5
Rockefeller Capital Management
5
Rockefeller Capital Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
$0 100 – –
CFGS
27
Concourse Financial Group Securities
Alabama
– – – –
Bank of America
28
Bank of America
North Carolina
$0 90 +16 +22%
1
2